Okyanos Heart Institute: Advancing Stem Cell Therapy

Okyanos Heart Institute is the first healthcare service provider in the world to offer this heart stem cell therapy procedure to patients in a state-of-the-art clinical setting. Okyanos is located in Freeport, Bahamas, an English speaking country, within easy reach of the U.S. shoreline.

We use the only European Union approved cell processing device available today. This technology has been used safely and effectively in multiple clinical trials to treat approximately 4,000 people across the globe, successfully treating a variety of ischemic (lack of blood flow) conditions.

We seek to work in close cooperation with the patient’s cardiologist to determine whether the procedure is expected to result in positive outcomes with  minimum risk based on protocols developed from the clinical trial results.

Okyanos Heart Institute’s goal is to ensure a completely positive patient experience including patient education on stem cells and treatments, registration, travel, familial support and, most importantly, medical treatment and follow-up.

We provide an on-line physician portal for primary cardiologist or internist  follow up and communication. Okyanos Heart Institute adheres to HIPAA compliancy rules and regulations.

To summarize:

• Okyanos Heart Institute is the first in the world to offer cardiac cell therapy for chronic coronary artery disease patients using a European Union approved cell processing device
• The cardiac stem cell therapy was subjected a double-blinded, randomized, placebo-controlled trial, PRECISE
• The study was performed by a prominent interventional cardiologist
• The healthcare service is delivered in a Center of Excellence; in Freeport, Bahamas, an English speaking country that recognizes EU standards
• The Institute is convenient to access via an international airport, FPO